Changeflow GovPing Healthcare & Life Sciences Patent Application: Conditioned Media, Cultured...
Routine Notice Added Draft

Patent Application: Conditioned Media, Cultured Cells Production

Favicon for changeflow.com USPTO Patent Applications - Biotech (C12N)
Published
Detected
Email

Summary

The USPTO has published a new patent application, US20260083818A1, detailing a system and method for the production, formulation, and use of conditioned media and cultured cells. The application was filed on May 7, 2025, and describes techniques for culturing various cell types, including animal and plant cells, together.

Published by USPTO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

This document is a published patent application from the USPTO, not a regulatory rule or guidance. It describes a novel technology for producing and formulating conditioned media and cultured cells, potentially for use in various biological applications. The application details methods for inoculating media with animal and plant cells, either simultaneously or sequentially, and culturing cells from different sources together.

While this is a patent application and not a direct regulatory requirement, it signals potential future innovations and intellectual property in the biotechnology and pharmaceutical sectors. Companies involved in cell culture, biomanufacturing, and the development of cell-based therapies should be aware of this filing as it may impact future product development, licensing opportunities, or competitive landscapes. No immediate compliance actions are required by this filing.

Archived snapshot

Mar 27, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Applications

System and Method for the Production, Formulation and Use of Conditioned Media, Cultured Cells and the Factors Included Therein

Application US20260083818A1 Kind: A1 Mar 26, 2026

Inventors

Nathan Newman, Alex Rajangam, Dodanim Talavera-Adame, Harpreet Sidhu

Abstract

A technology regarding the production, formulation and use of conditioned media and the factors included therein is disclosed. The conditioned media may be inoculated with animal cells, plant cells and any combination thereof. The inoculations may occur simultaneous or at different times. Cells retrieved from different areas of the animal and/or the plant may also be cultured together to form conditioned media and associated growth factors.

CPC Classifications

A61K 38/1709 A01H 4/002 A61K 9/0078 A61K 38/2026 A61K 38/204 A61K 38/2066 A61K 38/208 C12N 5/0656 C12N 5/0667 A61K 38/2093 A61K 38/217 C12N 2500/76

Filing Date

2025-05-07

Application No.

19201863

View original document →

Get daily alerts for USPTO Patent Applications - Biotech (C12N)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Published
May 7th, 2025
Instrument
Notice
Legal weight
Non-binding
Stage
Draft
Change scope
Minor
Document ID
US20260083818A1

Who this affects

Applies to
Drug manufacturers Pharmaceutical companies
Industry sector
3254 Pharmaceutical Manufacturing 3254.1 Biotechnology
Activity scope
Cell Culture Biomanufacturing
Geographic scope
United States US

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Research & Development
Topics
Biotechnology Medical Research

Get alerts for this source

We'll email you when USPTO Patent Applications - Biotech (C12N) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!